Back to Search
Start Over
47P First-line pembrolizumab (pembro) + gemcitabine and cisplatin (gem/cis) for advanced biliary tract cancer (BTC) in the China subpopulation from the phase III KEYNOTE-966 study.
- Source :
-
Annals of Oncology . 2024 Supplement 2, Vol. 35, pS230-S230. 1p. - Publication Year :
- 2024
- Subjects :
- *CISPLATIN
*PEMBROLIZUMAB
*GEMCITABINE
BILIARY tract cancer
Subjects
Details
- Language :
- English
- ISSN :
- 09237534
- Volume :
- 35
- Database :
- Academic Search Index
- Journal :
- Annals of Oncology
- Publication Type :
- Academic Journal
- Accession number :
- 179691475
- Full Text :
- https://doi.org/10.1016/j.annonc.2024.08.056